Literature DB >> 34035769

Nivolumab and Ipilimumab Combination Therapy for Second-Line Treatment of Hepatocellular Carcinoma.

Fadi Braiteh1.   

Abstract

Entities:  

Year:  2021        PMID： 34035769      PMCID： PMC8132719     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis.

Authors:  Giovanni Galati; Antonio Fabio Massimo Vainieri; Claudia Angela Maria Fulgenzi; Stefano Di Donato; Marianna Silletta; Paolo Gallo; Angelo Onorato; Umberto Vespasiani-Gentilucci; Antonio Picardi
Journal:  Curr Drug Metab       Date:  2020       Impact factor: 3.731

2.  The Role of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Pooled Analysis of 2,402 Patients.

Authors:  Ioannis A Ziogas; Alexandros P Evangeliou; Lipika Goyal; Georgios Tsoulfas; Dimitrios Giannis; Muhammad H Hayat; Konstantinos S Mylonas; Samer Tohme; David A Geller; Nahel Elias
Journal:  Oncologist       Date:  2021-01-02

3.  Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline.

Authors:  John D Gordan; Erin B Kennedy; Ghassan K Abou-Alfa; Muhammad Shaalan Beg; Steven T Brower; Terence P Gade; Laura Goff; Shilpi Gupta; Jennifer Guy; William P Harris; Renuka Iyer; Ishmael Jaiyesimi; Minaxi Jhawer; Asha Karippot; Ahmed O Kaseb; R Kate Kelley; Jennifer J Knox; Jeremy Kortmansky; Andrea Leaf; William M Remak; Rachna T Shroff; Davendra P S Sohal; Tamar H Taddei; Neeta K Venepalli; Andrea Wilson; Andrew X Zhu; Michal G Rose
Journal:  J Clin Oncol       Date:  2020-11-16       Impact factor: 44.544

4.  Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma.

Authors:  Bruno Sangro; Ignacio Melero; Samir Wadhawan; Richard S Finn; Ghassan K Abou-Alfa; Ann-Lii Cheng; Thomas Yau; Junji Furuse; Joong-Won Park; Zachary Boyd; Hao Tracy Tang; Yun Shen; Marina Tschaika; Jaclyn Neely; Anthony El-Khoueiry
Journal:  J Hepatol       Date:  2020-07-22       Impact factor: 25.083

5.  Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial.

Authors:  Thomas Yau; Yoon-Koo Kang; Tae-You Kim; Anthony B El-Khoueiry; Armando Santoro; Bruno Sangro; Ignacio Melero; Masatoshi Kudo; Ming-Mo Hou; Ana Matilla; Francesco Tovoli; Jennifer J Knox; Aiwu Ruth He; Bassel F El-Rayes; Mirelis Acosta-Rivera; Ho-Yeong Lim; Jaclyn Neely; Yun Shen; Tami Wisniewski; Jeffrey Anderson; Chiun Hsu
Journal:  JAMA Oncol       Date:  2020-11-12       Impact factor: 31.777
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.